After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.

Welcome back! The U.S. Supreme Court has struck down President Donald Trump’s emergency tariffs. Does this mean the global trade war is over? Let us know what you think. If this newsletter was ...

There are also plans to install solar-powered charging stations to provide more reliable sources of power, a key challenge ...

The FDA’s reversal of its earlier refusal to review mRNA-1010, the seasonal flu vaccine being developed by Moderna, accelerated a revival of Moderna shares that has been in progress over recent months ...